Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation

Human Molecular Genetics

Volumn 12, Issue 23, 2003, Pages 3161-3171

  Fernández Sánchez, Maria Elena ^a   Criado García, Olga ^a   Heath, Karen E ^a,d   García Fojeda, Belén ^a   Medraño Fernández, Iria ^a   Gomez Garre, Pilar ^b   Sanz, Pascual ^c   Serratosa, José María ^b   Rodríguez de Córdoba, Santiago ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; GLYCOGEN; GLYCOGEN SYNTHASE; LAFORIN; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CHROMOSOME 6Q; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MAPPING; GENE TARGETING; GENETIC CODE; GENETIC LINKAGE; GENETIC TRANSFECTION; GLYCOGEN METABOLISM; HOMOZYGOSITY; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; LINKAGE ANALYSIS; MISSENSE MUTATION; MOUSE; MYOCLONUS EPILEPSY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; CARRIER PROTEINS; COS CELLS; ESCHERICHIA COLI; GENES, RECESSIVE; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAFORA DISEASE; MICE; PHOSPHOPROTEIN PHOSPHATASE; PLASMIDS; PROTEIN-TYROSINE-PHOSPHATASE; RECOMBINANT FUSION PROTEINS; TRANSFORMATION, GENETIC;

ANIMALIA; MURINAE;

EID: 17644444332     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg340     Document Type: Article

References (28)

1. Berkovic, S.F., Andermann, F., Carpenter, S. and Wolfe, L.S. (1986) Progressive myoclonus epilepsies: specific causes and diagnosis. New Engl. J. Med., 315, 296-305.
2. Lafora, G.R. (1911) Über das Corkommen amyloider Körperchen im Innern der Ganglienzellen; zugliech Ein zum Studium der amyloiden Substanz im Nervensystem. Virchows Arch. Pathol. Anat., 205, 295-303.
3. Lafora, G.R. and Glueck, B. (1911) Beitrag zur Histogpathologie der myoklonischen Epilepsie. Z. Gesamte Neurol. Psychiatr., 6, 1-14.
4. Harriman, D.G.F. and Millar, J.H.D. (1955) Progressive familial myoclonic epilepsy in three families: its clinical features and pathological basics. Brain, 78, 325-349.
5. Yokoi, S., Austin, J., Witmer, F. and Sakai, M. (1968) Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch. Neurol., 19, 15-33.
6. Sakai, M., Austin, J., Witmer, F. and Trueb, L. (1970) Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology, 20, 160-176.
7. Serratosa, J.M., Delgado-Escueta, A.V., Posada, I., Shih, S., Drury, I., Berciano, J., Zabala, J.A., Antunez, M.C. and Sparkes, R.S. (1995) The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum. Mol. Genet., 4, 1657-1663.
8. Sainz, J., Minassian, B.A., Serratosa, J.M., Gee, M.N., Sakamoto, L.M., Iranmanesh, R., Bohlega, S., Baumann, R.J., Ryan, S., Sparkes, R.S. et al. (1997) Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygosities. Am. J. Hum. Genet., 6, 1205-1209.
9. Serratosa, J.M., Gómez-Garre, P., Gallardo, E., Anta, B., de Bernabé, D.B., Lindhout, D., Augustijn, P.B., Tassinari, C.A., Michelucci, R., Malafosse, A. et al. (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum. Mol. Genet., 8, 345-352.
10. Minassian, B.A., Sainz, J., Serratosa, J.M., Gee, M., Sakamoto, L.M., Bohlega, S., Geoffroy, G., Barr, C., Scherer, S.W., Tomiyasu, U. et al. (1999) Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy. Ann. Neurol., 45, 262-265.
11. Ganesh, S., Shoda, K., Amano, K., Uchiyama, A., Kumada, S., Moriyama, N., Hirose, S. and Yunakawa, K. (2001) Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene. Mol. Cell Probes, 15, 281-289.
12. Minassian, B.A., Lee, J.R., Herbrick, J.A., Huizenga, J., Soder, S., Mungall, A.J., Dunham, I., Gardner, R., Fong, C.G., Carpenter, S. et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet., 20, 171-174.
13. Gómez-Garre, P., Sanz, Y., Rodríguez de Córdoba, S. and Serratosa, J.M: (2000) Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions. Eur. J. Hum. Genet., 8, 946-954.
14. Minassian, B.A., Ianzano, L., Meloche, M., Andermann, E., Rouleau, G.A., Delgado-Escueta, A.V. and Scherer, S.W. (2000) Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology, 55, 341-346.
15. Ganesh, S., Delgado-Escueta, A.V., Sakamoto, T., Avila, M.R., Machado-Salas, J., Hoshii, Y., Akagi, T., Gomi, H., Suzuki, T., Amano, K. et al. (2002) Targeted disruption of the EPM2A gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet., 11, 1251-1262.
16. Wang, J., Stuckey, J.A., Wishart, M.J. and Dixon, J.E. (2002) A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem., 277, 2377-2380.
17. Ganesh, S., Agarwala, K.L., Ueda, K., Akagi, T., Shoda, K., Usui, T., Hashikawa, T., Osada, H., Delgado-Escueta, A.V. and Yamakawa, K. (2000) Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum. Mol. Genet., 9, 2251-2261.
18. Doherty, M.J., Young, P.R. and Cohen, P.T.W. (1996) Amino acid sequence of a novel protein phosphatase 1 binding protein (R5) which is related to the liver-and muscle-specific glycogen binding subunits of protein phosphatase 1. FEBS Lett., 399, 339-343.
19. Printen, J.A., Brady, M.J. and Saltiel, A.R. (1997) PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science, 275, 1475-1478.
20. Fong, N.M., Jensen, T.C., Shah, A.S., Parekh, N.N., Saltiel, A.R. and Brady, M.J. (2000) Identification of binding sites on protein targeting to glycogen for enzymes of glycogen metabolism. J. Biol. Chem., 275, 35034-35039.
21. Zhong-Yin, Z., Wang, Y. and Dixon, J.E. (1994) Dissecting the catalytic mechanism of protein-tyrosine phosphatases. Proc. Natl Acad. Sci. USA, 91, 1624-1627.
22. Browne, G.J., Delibegovic, M., Keppens, S., Stalmans, W. and Cohen, P.T.W. (2001) The level of the glycogen targetting regulatory subuinit R5 of protein phosphatase 1 is decrease in the livers of insulin-dependient diabetic rats and starved rats. Biochem. J., 360, 449-459.
23. Gomis, R.R., Ferrer, J.C. and Guinovart, J.J. (2000) Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase. Biochem. J., 351, 811-816.
24. Berman, H.K., O'Doherty, R.M., Anderson, P. and Newgard, C.B. (1998) Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms. J. Biol. Chem., 273, 26421-26425.
25. O'Doherty, R.M., Jensen, P.B., Anderson, P., Jones, J.G., Berman, H.K., Kearney, D. and Newgard, C.B. (2000) Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. J. Clin. Invest., 105, 479-488.
26. Greenberg, C.C., Meredith, K.N., Yan, L. and Brady, M.J. (2003) Protein targeting to glycogen overexpression results in the specific enhancement of glycogen storage in 3T3-L1 adipocytes. J. Biol. Chem., 15, 30835-30842.
27. Ker-hwa Ou, S., Ming-chen Hwang, J. and Patterson, P.H. (1993) A modified method for obtaining large amounts of high titer polyclonal ascites fluid. J. Immunol. Meth., 165, 75-80.
28. Feinberg, A.P. and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 1, 6-13.